These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20082125)

  • 21. How the binding and degrading capabilities of insulin degrading enzyme are affected by ubiquitin.
    Grasso G; Rizzarelli E; Spoto G
    Biochim Biophys Acta; 2008; 1784(7-8):1122-6. PubMed ID: 18489915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor.
    Shabanpoor F; Zhang S; Hughes RA; Hossain MA; Layfield S; Ferraro T; Bathgate RA; Separovic F; Wade JD
    Biopolymers; 2011; 96(1):81-7. PubMed ID: 20560146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catalytic Mechanism of Amyloid-β Peptide Degradation by Insulin Degrading Enzyme: Insights from Quantum Mechanics and Molecular Mechanics Style Møller-Plesset Second Order Perturbation Theory Calculation.
    Lai R; Tang WJ; Li H
    J Chem Inf Model; 2018 Sep; 58(9):1926-1934. PubMed ID: 30133282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
    Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
    J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
    Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
    J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.
    Affholter JA; Hsieh CL; Francke U; Roth RA
    Mol Endocrinol; 1990 Aug; 4(8):1125-35. PubMed ID: 2293021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression analyses of insulin-like peptide 3, RXFP2, LH receptor, and 3β-hydroxysteroid dehydrogenase in testes of normal and cryptorchid dogs.
    Hannan MA; Kawate N; Kubo Y; Pathirana IN; Büllesbach EE; Hatoya S; Inaba T; Takahashi M; Tamada H
    Theriogenology; 2015 Oct; 84(7):1176-84. PubMed ID: 26220663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological properties of an initial degradation product of insulin by insulin-degrading enzyme.
    Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Sakamoto T; Kawase Y; Akiyama H; Taketomi S; Baba S
    Endocrinology; 1989 Jan; 124(1):496-504. PubMed ID: 2642422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of residues in the insulin molecule important for binding to insulin-degrading enzyme.
    Affholter JA; Cascieri MA; Bayne ML; Brange J; Casaretto M; Roth RA
    Biochemistry; 1990 Aug; 29(33):7727-33. PubMed ID: 2271531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-covalent interaction of ubiquitin with insulin-degrading enzyme.
    Saric T; Müller D; Seitz HJ; Pavelic K
    Mol Cell Endocrinol; 2003 Jun; 204(1-2):11-20. PubMed ID: 12850277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme.
    Bennett RG; Fawcett J; Kruer MC; Duckworth WC; Hamel FG
    J Endocrinol; 2003 Jun; 177(3):399-405. PubMed ID: 12773120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of zinc ligands of the insulin-degrading enzyme.
    Perlman RK; Rosner MR
    J Biol Chem; 1994 Dec; 269(52):33140-5. PubMed ID: 7806544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IDE Degrades Nociceptin/Orphanin FQ through an Insulin Regulated Mechanism.
    Zingale GA; Bellia F; Ahmed IMM; Mielczarek P; Silberring J; Grasso G
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 1997 Feb; 46(2):197-203. PubMed ID: 9000694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
    Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
    Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of indole-based activators of insulin degrading enzyme.
    Kraupner N; Dinh CP; Wen X; Landry V; Herledan A; Leroux F; Bosc D; Charton J; Maillard C; Warenghem S; Duplan I; Piveteau C; Hennuyer N; Staels B; Deprez B; Deprez-Poulain R
    Eur J Med Chem; 2022 Jan; 228():113982. PubMed ID: 34815130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.
    Chesneau V; Vekrellis K; Rosner MR; Selkoe DJ
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):509-16. PubMed ID: 11023838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The insulin-like factor 3 (INSL3)-receptor (RXFP2) network functions as a germ cell survival/anti-apoptotic factor in boar testes.
    Sagata D; Minagawa I; Kohriki H; Pitia AM; Uera N; Katakura Y; Sukigara H; Terada K; Shibata M; Park EY; Hasegawa Y; Sasada H; Kohsaka T
    Endocrinology; 2015 Apr; 156(4):1523-39. PubMed ID: 25562614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.